Navigation Links
Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note
Date:11/9/2009

WOODCLIFF LAKE, N.J., Nov. 9 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that it has extended the expiration date and increased the purchase price of its previously announced "Modified Dutch Auction" tender offer, in which Par is offering to purchase, for cash, up to $65,000,000 aggregate principal amount, or up to approximately 82.7%, of its outstanding 2.875% Senior Subordinated Convertible Notes due 2010.

The price for the offer to purchase the convertible notes includes accrued and unpaid interest thereon up to, but not including, the date of purchase of the convertible notes, and has increased from a price (in multiples of $0.50 per $1,000 principal amount) not greater than $990.00 nor less than $982.50 per $1,000 principal amount to a price not greater than $1,000.00 nor less than $982.50 per $1,000 principal amount.

The deadline for tendering convertible notes in the offering has been extended from 12:00 midnight, New York City time, on Wednesday, November 11, 2009, to 12:00 midnight, New York City time, on Tuesday, November 24, 2009, unless further extended.

The Company has been advised that as of 5:00 p.m., New York City time, on November 6, 2009, approximately $4,345,000 of the convertible notes had been tendered in the Offer.

About Par Pharmaceutical

Par Pharmaceutical Companies, Inc. develops, manufactures and markets generic drugs and innovative branded pharmaceuticals for specialty markets. For press releases and other company information, visit www.parpharm.com.

Tender Offer Statement

This press release is for informational purposes only and is neither an offer to buy nor the solicitation of an offer to sell any securities. The full details of the tender of
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments
2. ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI)
3. Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration
4. DUSA Pharmaceuticals to Present at the Merriman Curhan Ford Investor Summit 2009
5. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution
6. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST
7. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution
8. Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12
9. Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results
10. Jazz Pharmaceuticals Announces Third Quarter 2009 Financial Results
11. Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...sResearchGroup,Inc.releasedWave1ofits LaunchTrend...ndicatedmarketresearchprojecttrackingthelaunchofCe...ughthefirstsixmonthsofavailability.Eachwaveofthere...matologistsandqualitativeinformationfromasubsetof2...use,typicalpatienttypes,productperceptions,promoti...
(Date:11/25/2009)...irstCall/--FormanyofthemillionsofhearingimpairedAm...hearingloss ,theholidaysmaynotbeallthathappy,saysa...sidentofHearUSA(Amex: EAR ),oneofAmerica,slargesth...elinkedhearinglosstostress,frustration,andsocialis...ringswithfamiliesandfriends,whenmanyofthosewithhea...
(Date:11/25/2009).../--AMPACFineChemicalsLLC(AFC),asubsidiaryofAmerica...atitreceivedtheEnvironmentalResponsibilityandSusta...mit,sponsoredbytheCaliforniaManufacturersandTechno...sociation(IEA)andtheChemicalIndustryCouncilofCalif...awardavailablefromallthreeorganizationsandgainssub...
Breaking Medicine Technology:Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2Caraco Pharmaceutical Laboratories Ltd Markets Generic Imitrex 28R 29 Tablets 54270 1Caraco Pharmaceutical Laboratories Ltd Markets Generic Imitrex 28R 29 Tablets 54270 2HearUSA Makes Hearing Aids and Care Available to AARP Members 54269 1HearUSA Makes Hearing Aids and Care Available to AARP Members 54269 2HearUSA Makes Hearing Aids and Care Available to AARP Members 54269 3HearUSA Makes Hearing Aids and Care Available to AARP Members 54269 4West to Present at the Ninth Annual CJS Securities New Ideas Summer Conference 54267 1
... June 20, 2007 /PRNewswire-FirstCall/ - SemBioSys,... a portfolio of,therapeutic proteins for metabolic...it will be presenting a scientific poster and,abst...an Diabetes,Association (ADA) in Chicago. The Comp...in the development of a highly-scalable, low,cost ...
...IRE)--Jun 20, 2007 - Neoprobe Corporation,(OTCBB:N...gy and,cardiovascular surgical and diagnostic prod... from a multicenter Phase 2 clinical,study of its ...,Tc99m DTPA-mannosyl-dextran). Lymphoseek is a pro...ed for use with handheld,gamma detection devices, ...
Other Medicine Technology:SemBioSys to present new data at American Diabetes Association,annual meeting 2SemBioSys to present new data at American Diabetes Association,annual meeting 3Neoprobe Phase 2 Lymphoseek Trial Meets Primary Endpoint 2Neoprobe Phase 2 Lymphoseek Trial Meets Primary Endpoint 3
(Date:11/25/2009)...evidence of a statistically significant survival b...e estrogen receptor (ER)-positive tumors had high ...18 (ER-alpha S118-P), according to a brief communi...l of the National Cancer Institute . , Approxima...oxifen. Preclinical studies have shown that ER-alp...
(Date:11/25/2009)...d was too short to draw definite conclusions, expe...Day News) -- In diabetic patients with blocked cor...in outcomes at one year whether patients undergo b...h researchers report. , Bypass surgery has been... coronary artery disease. However, less invasive a...
(Date:11/25/2009)...uld lead mothers to overlook needed care, study fi...ws) -- A mother,s depression can worsen her child,...six-month study of 262 black mothers and their chi...epressive symptoms had more frequent asthma sympto...e symptoms had less frequent asthma symptoms. ,...
(Date:11/25/2009)...Newswire/-- MISSIONSkincare ®isproudtosupport...artofGNC,sannualSt.Jude ThanksandGiving campaign,$...w SUPER-C(TM)LipBalm willbedonatedtoSt.Jude.Addit...or$10donationatcheckoutatoneoftheir5,000+retailloc...forSt.Judeduringtheir2009 ThanksandGiving campaign...
(Date:11/25/2009)...ancer vaccine carried into the body on a carefully... to successfully eliminate tumors in mammals, scie...anslational Medicine . , The new approach, pione...University, uses plastic disks impregnated with tu... to reprogram the mammalian immune system to attac...
Breaking Medicine News(10 mins):Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Mom's Depression May Worsen Child's Asthma 2Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2
... New treatment option for the estimated 6 million ...ondition , , NEW YORK and SAN DIEGO, Jan. 14, 200...press Bioscience, Inc. (Nasdaq: CYPB ) today ann...ministration (FDA) for the management of fibromyal...
... NEW YORK, Jan. 14 David Welch, a great friend to...rain cancer on January 7th at his mother,s home, s...ness with courage and dignity. Through his effort...ain cancer. So named because of his diagnosis of ...
... FRANKLIN LAKES, N.J., Jan. 14 BD (Becton, Dickin...technology company, announced today that it will h...olders on Tuesday, February 3, 2009, at 1 p.m. (ET... 10, 2009. , , BD is a leading global medical tec...
... HARBIN, China, Jan. 14 /PRNewswire-Asia-First...ulletin Board: SOKF), a leading operator of fitnes...d its operating results for the,fiscal second quar...nths ended November 30, 2008, revenues,were $8.88 ...
... WASHINGTON, Jan. 14 Speaker Nancy Pelosi spoke ... of H.R. 2, the State Children,s Health Insurance ...passed by a strong bipartisan vote of 289 to 139. ...te, the House will bring us one step closer to pro...
... BATTLE CREEK, Mich., Jan. 14 Kellogg Company...cautionary measure of putting a,hold on Austin(R) ...ich,Crackers, Peanut Butter and Jelly Sandwich Cra...ed that Peanut Corporation,of America (PCA) is the...
Other Medicine News:Health News:Forest and Cypress Announce FDA Approval of Savella(TM) for the Management of Fibromyalgia 2Health News:Forest and Cypress Announce FDA Approval of Savella(TM) for the Management of Fibromyalgia 3Health News:Forest and Cypress Announce FDA Approval of Savella(TM) for the Management of Fibromyalgia 4Health News:Forest and Cypress Announce FDA Approval of Savella(TM) for the Management of Fibromyalgia 5Health News:Forest and Cypress Announce FDA Approval of Savella(TM) for the Management of Fibromyalgia 6Health News:Forest and Cypress Announce FDA Approval of Savella(TM) for the Management of Fibromyalgia 7Health News:Forest and Cypress Announce FDA Approval of Savella(TM) for the Management of Fibromyalgia 8Health News:SOKO Fitness & Spa Group Announces Second Quarter FY2009 Financial Results 2Health News:SOKO Fitness & Spa Group Announces Second Quarter FY2009 Financial Results 3Health News:Pelosi: SCHIP Vote Brings Us One Step Closer to Providing Health Care for 11 Million Children 2Health News:Pelosi: SCHIP Vote Brings Us One Step Closer to Providing Health Care for 11 Million Children 3Health News:Kellogg Company Announces Precautionary Hold on Austin and Keebler Branded Peanut Butter Sandwich Crackers 2
Cutting Burr with Dental Shank
Rosen Burr
...re designed exclusively for video endoscopy and ar...opy systems. When used in conjunction with our inn... sharp, high-resolution images with excellent colo...details - necessary for accurate diagnosis. They p...
...V lines of resolution with RGB, s-video and compos...ns, scanning size selection and DC output availabi...o easily set up and operate the medical grade moni..., contrast, volume and aperture control. It also f...
Medicine Products: